Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Leng will become NICE chief executive; plus BMS, Sofinnova, Medicxi, PTC, Orchard and more

March 19, 2020 1:12 AM UTC
Updated on Mar 21, 2020 at 12:20 AM UTC

The U.K.'s NICE said Gillian Leng will become chief executive, effective April 1, succeeding Andrew Dillon, who is stepping down. Leng was NICE's deputy chief executive and director of health and social care. Separately, the country's MHRA said it is accepting applications for chair of the agency through March 24.

Bristol Myers Squibb Co. (NYSE:BMY) hired Elizabeth Mily as EVP of strategy and business development. She was managing director and chair of the global life sciences group at Barclays. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article